Sauder Schelkopf is investigating a potential class action lawsuit on behalf of individuals who used EzriCare Artificial Tears. EzriCare Artificial Tears is an over-the-counter eye drop designed to relieve eye irritation and dryness. Recent epidemiology and laboratory evidence link EzriCare Artificial Tears with eye and other infections.
On January 20, 2023, the Centers for Disease Control and Prevention (CDC) urged immediate discontinued use of EzriCare Artificial Tears and stated that it is investigating a cluster of 56 isolates from 50 patients in 11 states (CA, CO, CT, FL, NJ, NM, NV, NY, TX, UT, WA). Of this cluster, patients have suffered permanent vision loss, hospitalization, and infection in the bloodstream which caused death.
Eye infections can cause varying levels of vision loss, damage to the retina, scars, and ulcers in the cornea. An infection can also spread to other parts of the body and threaten other organs. Eye infection symptoms include:
- Blurry vision
- Dry eyes
- Eye discharge
- Eye pain
- Itching
- Light sensitivity
- Swollen eyes and/or surrounding areas
Related News
Eye Drops Are Recalled After Being Linked to Vision Loss and 1 Death
Experience Matters
Sauder Schelkopf has a nationally recognized litigation practice. The firm currently serves as court-appointed lead counsel in courts across the country. The attorneys at Sauder Schelkopf have recovered over $500 million on behalf of their clients and class members. Our firm was recognized by the Legal Intelligencer’s 2022 Professional Excellence Awards. The Legal Intelligencer’s Professional Excellence Awards honor Pennsylvania law firms and attorneys who have made a significant, positive impact on the legal profession. Our firm was named in the Litigation Departments of the Year (Specialty Area category; runner-up), an award that honors the best litigation practice in a small or mid-sized firm in Pennsylvania. This recognition was based on the firm’s 2021 litigation work and its important ongoing cases. LawDragon has recognized our attorneys in its list of the “500 Leading Plaintiff Consumer Lawyers” for 2022. This list notes: “From the opioid epidemic to toxic substances and defective products, truck accidents to wildfires and sexual abuse, these are the lawyers who stand on the front line in individual lawsuits and class actions seeking justice.” Mr. Schelkopf was named to Pennsylvania’s Best Lawyers® 2022 for Class Actions/Mass Tort Litigation. The American Lawyer named Mr. Sauder to its 2021 Northeast Trailblazers. The honor recognizes 60 lawyers who are “truly agents of change.” It “recognizes professionals in the Northeast who have moved the needle in the legal industry.” The Legal Intelligencer named Mr. Sauder and Mr. Schelkopf in its 2020 Pennsylvania Trailblazers list recognizing 31 lawyers who “have taken extra measures to contribute to positive outcomes . . . and who are truly agents of change.” The Legal highlighted the firm’s innovative work on advocacy as class counsel in large institutional sex abuse cover-ups, women’s, and children’s rights. Our attorneys have also consistently been recognized by their peers being named to Pennsylvania SuperLawyer, a distinction held by the top 5% of attorneys in Pennsylvania. The National Trial Lawyers Association has also selected our attorneys as the Top 100 Trial Lawyers in Pennsylvania.
We Want to Hear from You
If you used EzriCare Artificial Tears and have experienced an eye infection, please contact the attorneys at Sauder Schelkopf by completing the form on this page.